TA
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Physical instability, aggregation and conformational changes of recombinant human bone morphogenetic protein-2 (rhBMP-2) | International journal of pharmaceutics | 2010 | 686 | 0 | |||
| A high throughput protein formulation platform: case study of salmon calcitonin | Pharmaceutical research | 2009 | 660 | 710 | |||
| Toward the understanding of the photodynamic activity of m-THPP encapsulated in PLGA nanoparticles: correlation between nanoparticle properties and in vivo activity | Journal of Drug Targeting | 2009 | 422 | 1 | |||
| High throughput methods to characterize protein permeation and release | International journal of pharmaceutics | 2008 | 858 | 3 | |||
| Characterization of protein aggregation: the case of a therapeutic immunoglobulin | Biochimica et biophysica acta | 2007 | 647 | 0 | |||
| Detection and characterization of protein aggregates by fluorescence microscopy | International journal of pharmaceutics | 2007 | 653 | 0 | |||
| High throughput screening of protein formulation stability: practical considerations | European journal of pharmaceutics and biopharmaceutics | 2007 | 659 | 0 | |||
| Where disease pathogenesis meets protein formulation: renal deposition of immunoglobulin aggregates | European journal of pharmaceutics and biopharmaceutics | 2006 | 387 | 1 | |||
| Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicity | Vaccine | 2005 | 45 | 0 |
